Peregrine Pharmaceuticals reported $9.19M in Gross Profit on Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Agenus AGEN:US $ 25.4M 6.02M
Amgen AMGN:US $ 4677M 451M
AstraZeneca AZN:LN 8.94B 2.9B
Biocryst Pharmaceuticals BCRX:US $ 49.68M 2.95M
Bristol Myers Squibb BMY:US $ 9177M 452M
ChemoCentryx CCXI:US 5.25M 3.24M
Eli Lilly And LLY:US $ 5737.9M 211.8M
GlaxoSmithKline GSK:LN 6.14B 283M
Intrexon XON:US $ 6.11M 12.44M
Karyopharm Therapeutics KPTI:US $ 46.24M 79.28M
MacroGenics MGNX:US 11.05M 2.15M
Mannkind MNKD:US $ 0.99M 0.09M
Merk MRK:US $ 10567M 873M
Novartis NOVN:VX 9.52B 3M
Peregrine Pharmaceuticals PPHM:US $ 9.19M 2.2M
Repligen RGEN:US $ 124.04M 19.57M